The Immunology Podcast cover image

IMMUNOLOGY2024™: Day 4

The Immunology Podcast

CHAPTER

Advancements in TIL Therapy and Vaccine-Prime T Cell Research

This chapter highlights a successful phase two trial of tumor-infiltrating lymphocyte therapy for metastatic melanoma, which achieved a 31% response rate and prompted FDA acceleration. It also discusses future trials, the integration of PD-1 inhibitors, and innovative vaccination strategies to enhance adoptive immunotherapy.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner